Combined Immunomodulatory Therapy in Autoimmune Autonomic Ganglionopathy
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Autoimmune autonomic ganglionopathy is a disorder defined by antibodies to the nicotinic acetylcholine receptor of the autonomic ganglia. Patients present with symptoms of autonomic failure, including syncope, orthostatic hypotension, bowel and bladder hypomotility, pupillary dysfunction, and dry mouth and eyes. Symptomatic and immunomodulatory therapy has provided limited clinical benefit in small uncontrolled studies. OBJECTIVE: To investigate the effects of combined immunosuppressive therapy and plasmapheresis in autoimmune autonomic ganglionopathy. DESIGN: Prospective case series. SETTING: Academic medical center. PATIENTS: Three patients with autoimmune autonomic ganglionopathy who had a limited response to symptomatic therapy, such as midodrine, fludrocortisone, vasopressin, and erythropoietin. Additional treatment with plasmapheresis alone and intravenous immunoglobulin alone provided no additional clinical benefit. Patients underwent 6 months of treatment with prednisone and mycophenolate mofetil followed by 5 cycles of plasma exchange. RESULTS: Immunosuppressive therapy (prednisone and mycophenolate mofetil) combined with plasmapheresis resulted in substantial improvements in bowel control, pupillary function, dry mouth, and dry eyes. Mean (SD) blood pressure during immunosuppressive therapy was 162/83 (16/12) mm Hg supine and 76/45 (22/11) mm Hg standing (3 minutes). After 5 cycles of plasmapheresis, mean blood pressure was 132/82 (7/4) mm Hg supine and 127/81 (5/1) mm Hg standing (3 minutes; P < .01). Mean antibody level was 7.92 nmol/L on combined immunosuppressive therapy alone and dropped to 0.5 nmol/L after plasmapheresis. CONCLUSIONS: In patients with autoimmune autonomic ganglionopathy, combining immunosuppressive medications prednisone and mycophenolate mofetil with plasmapheresis provides substantial and sustained clinical improvement that was not seen using either treatment alone. Multi-agent immunomodulatory therapies may be necessary to satisfactorily treat this immune-mediated disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies
Vernino, S., Low, P. A., Fealey, R. D., Stewart, J. D., Farrugia, G., & Lennon, V. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009213431204 · Cited by 674 · cited 2×
“Antibodies to neuronal ganglionic AChR were detected by radioimmunoprecipitation assay as previously described.(4) Patients underwent autonomic testing at initial diagnosis, the week prior to plasmapheresis (while receiving combined immunosuppressive therapy with prednisone and mycophenolate mofetil), and 1 week postp…”
BackgroundMethodImmunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease
Lennon, V. A., Ermilov, L. G., Szurszewski, J. H., & Vernino, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17429 · Cited by 178
Self-citation
Cited by
The pattern and diagnostic criteria of sensory neuronopathy: a case-control study
Camdessanche, J.-P., Jousserand, G., Ferraud, K., Vial, C., Petiot, P., Honnorat, J., & Antoine, J.-C. (2009) · Brain · doi:10.1093/brain/awp136 · Cited by 262
Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy
Vernino, S., Hopkins, S., & Wang, Z. (2009) · Autonomic Neuroscience · doi:10.1016/j.autneu.2008.09.005 · Cited by 123
Self-citationThe clinical approach to autonomic failure in neurological disorders
Benarroch, E. E. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.88 · Cited by 71
Schofield, J. R., & Chemali, K. R. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000778 · Cited by 55
Wang, Z., Low, P. A., & Vernino, S. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.016 · Cited by 34
“In some cases, patients treated with plasma exchange or other immunomodulatory treatments to reduce antibody levels can show dramatic improvement in autonomic function (Gibbons et al., 2008; Schroeder et al., 2005).”
Self-citation
Metadata
- Authors
- Gibbons, C. H., Vernino, S. A., & Freeman, R.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2008-02-01
- Volume
- 65
- Issue
- 2
- Pages
- 213-7
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2090713933
- Cited by
- 83
- References
- 2
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined Immunomodulatory Therapy in Autoimmune Autonomic Ganglionopathy. https://app.cochat.ai/papers/10.1001/archneurol.2007.60
- The paper
- Gibbons, C. H., Vernino, S. A., & Freeman, R. (2008). Combined Immunomodulatory Therapy in Autoimmune Autonomic Ganglionopathy. Archives of Neurology. https://doi.org/10.1001/archneurol.2007.60
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.